MD Nexus

Tebentafusp-Tebn (Kimmtrak)

Indications

Uveal Melanoma (see Melanoma)

Clinical Efficacy

Pharmacology

XXXXX

Metabolism

Administration

XXXXX

Dose Adjustment

Use in Pregnancy (see Pregnancy)

Use During Breast Feeding

Adverse Effects

Cardiovascular Adverse Effects

Hypotension (see xxxx)

  • Epidemiology
    • XXXX

Dermatologic Adverse Effects

Dry Skin (see xxxx)

  • Epidemiology
    • XXXX

Pruritus (see xxxx)

  • Epidemiology
    • XXXX

Rash

  • Epidemiology
    • XXXX

Gastrointestinal Adverse Effects

Abdominal Pain (see Abdominal Pain)

  • Epidemiology
    • XXXX

Elevated Liver Function Tests (LFT’s) (see xxxx)

  • Epidemiology
    • XXXX

Nausea/Vomiting (see Nausea and Vomiting)

  • Epidemiology
    • XXXX

Immunologic Adverse Effects

Cytokine Release Syndrome (see Cytokine Release Syndrome)

  • Epidemiology
    • XXXX
  • Treatment

Neurologic Adverse Effects

Fatigue (see xxxx)

  • Epidemiology
    • XXXX

Headache (see Headache)

  • Epidemiology
    • XXXX

Rheumatologic/Orthopedic Adverse Effects

Peripheral Edema (see Peripheral Edema)

  • Epidemiology
    • XXXX

Other Adverse Effects

Chills (see xxxx)

  • Epidemiology
    • XXXX

Fever (see xxxx)

  • Epidemiology
    • XXXX

References

General